Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes

Eur J Biochem. 2002 Jan;269(1):29-37. doi: 10.1046/j.0014-2956.2002.02626.x.

Abstract

It has previously been shown that IFN-alpha is a potent inhibitor of IL-2 induced proliferation in primary T-lymphocytes, by selectively abrogating the downstream effects of IL-2 on the core cell cycle machinery regulating the G1/S transition. Theoretically this could be mediated through cross-talk between the signalling cascades activated by these cytokines, as several signalling components are known to be shared. IL-2 activates multiple signalling pathways that are important for T-cell proliferation and differentiation. In the present study, the effects of IFN-alpha on IL-2 signal transduction was investigated. The IFN-alpha induced inhibition of IL-2 induced proliferation in activated T-lymphocytes, was associated with a suppressed Jak3 protein expression as well as an inhibited prolonged Stat5 DNA binding, and a partially reduced expression of the Stat5 inducible gene IL-2R alpha. Our results provide a possible molecular link between the prominent antiproliferative effects of IFN-alpha on IL-2 induced T-cell proliferation and the signal transduction pathways emerging from the IL-2 receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • DNA / metabolism*
  • DNA-Binding Proteins / metabolism*
  • Humans
  • Interferon-alpha / pharmacology*
  • Interleukin-2 / pharmacology*
  • Janus Kinase 3
  • Milk Proteins*
  • Phosphatidylinositol 3-Kinases / physiology
  • Phosphorylation
  • Protein-Tyrosine Kinases / biosynthesis
  • STAT5 Transcription Factor
  • T-Lymphocytes / metabolism*
  • Trans-Activators / metabolism*
  • Transcription, Genetic / drug effects

Substances

  • DNA-Binding Proteins
  • Interferon-alpha
  • Interleukin-2
  • Milk Proteins
  • STAT5 Transcription Factor
  • Trans-Activators
  • DNA
  • Phosphatidylinositol 3-Kinases
  • Protein-Tyrosine Kinases
  • JAK3 protein, human
  • Janus Kinase 3